drugset / Trial / NCT02213159

Dexmedetomidine for Postoperative Analgesia After Bariatric Surgery

NCT02213159

Phase 2/3 Completed 60 enrolled American University of Beirut Medical Center
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine if Dexmedetomidine given at the end of surgery will reduce postoperative morphine consumption and improve postoperative quality of recovery as compared to morphine in patients undergoing laparoscopic bariatric surgery.

Timeline

Start
2014-07
Primary completion
2015-11
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Comparator Morphine Other / unclassified 0.08 mg/kg Intravenous